Outset Medical, Inc.
OM
$15.04
-$1.02-6.35%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 35.45% | 33.58% | 39.50% | 21.78% | 9.16% |
| Total Depreciation and Amortization | -11.37% | -2.77% | -5.12% | -2.84% | 5.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 42.00% | -35.20% | -34.72% | 24.77% | -6.63% |
| Change in Net Operating Assets | 18.65% | -47.60% | -145.10% | -333.42% | -43.55% |
| Cash from Operations | 44.10% | 32.54% | 39.50% | -18.31% | -2.58% |
| Capital Expenditure | 65.25% | 95.92% | 49.49% | 84.91% | 56.30% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -32.86% | 342.01% | -46.81% | 39.76% | -1,799.30% |
| Cash from Investing | -32.27% | 361.70% | -46.74% | 43.41% | -2,333.48% |
| Total Debt Issued | 47.72% | -100.00% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -80.44% | -100.00% | -97.05% | -92.62% | -60.47% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -18.88% | -102.82% | -97.05% | -92.62% | 1,200.17% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -32.35% | 181.66% | -4,924.18% | 28,315.00% | 1.37% |